# Amgen Inc. (AMGN) — Q2-2009 Earnings Results

**Report date:** 2009-07-27 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q2-2009

## Post-Earnings Brief

### Headline

Amgen Beats on EPS, Stock Down 0.25%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.29 | N/A | +12.08% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed confidence in their product pipeline and ongoing R&D efforts. However, they did not provide specific guidance for future quarters.

**Key quotes:**

> Management highlighted strong performance in key therapeutic areas.

> They noted ongoing investments in research and development.

> There was an emphasis on maintaining a strong pipeline of products.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Amgen's earnings report showed a positive surprise on EPS, indicating better-than-expected profitability. However, the stock reacted negatively, declining by 0.25%. This could suggest that investors were looking for more comprehensive revenue details or future guidance, which were not provided.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q2-2009_